Shilin Xu

1 ta ish

Renji Hospital

1. Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status

   Yongsong Wu, Shilin Xu, Shanshan Cheng +2

   Sharh maqola20233 iqtibos

   ABIABI:AkademIndex/2026.other.448100